ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.
1d
‘We call it ‘the pretzel’: First-of-its-kind bladder cancer treatment now in use in Maryland
An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback